Recntly, after the review and confirmation of the science and technology bureaus of various districts and countries (cities), Westlakeomics Omics (Hangzhou) Biotechnology Co., Ltd. was accredited with the Zhejiang Provincial Science and Technology Small and Medium-sized Enterprises certificate in 2021.
Chen Chen, R&D director of Westlake Omics, said, “Although Westlake Omics is a start-up company, our technical team has rich experience in mass spectrometry-based high-throughput proteomic analysis for trace biological samples. And our AI-empowered proteomic big data analysis technology is leading the way nationwide. In the future, we will devote ourselves to the iteration of proteomics technology, the development of AI-assisted pharmaceutical processes and new drug targets, as well as pushing for more clinical translation of new technologies and new products.”
Recntly, after the review and confirmation of the science and technology bureaus of various districts and countries (cities), Westlakeomics Omics (Hangzhou) Biotechnology Co., Ltd. was accredited with the Zhejiang Provincial Science and Technology Small and Medium-sized Enterprises certificate in 2021.
Chen Chen, R&D director of Westlake Omics, said, “Although Westlake Omics is a start-up company, our technical team has rich experience in mass spectrometry-based high-throughput proteomic analysis for trace biological samples. And our AI-empowered proteomic big data analysis technology is leading the way nationwide. In the future, we will devote ourselves to the iteration of proteomics technology, the development of AI-assisted pharmaceutical processes and new drug targets, as well as pushing for more clinical translation of new technologies and new products.”
